Free tool
Healthcare stocks
We cover 22 companies in the Healthcare sector. The median market value in the group is $60.35M. Across the group, the median move over the past trading day is +0.21%. 23% of the 22 with a 200-day average trade above it. Price change over the past year runs from −77.7% to +10.1% across the middle 80 percent of the group, with a median of −26.0%.
Other lists in this group
Table
22 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% | Sep 1, 2026 |
| SIG.AX | Sigma Healthcare Limited | 2.59 AUD | −13.09% | −11.26% | −15.21% | Aug 27, 2026 |
| COO | The Cooper Companies, Inc. | $72.68 | +0.86% | −10.39% | −1.93% | Sep 9, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% | Sep 21, 2026 |
| ABVX | ABIVAX Société Anonyme | $116.52 | −6.21% | −12.90% | +46.70% | Sep 21, 2026 |
| NNOX | Nano-X Imaging Ltd. | $0.88 | −0.25% | −69.05% | −77.77% | Sep 9, 2026 |
| CSBR | Champions Oncology, Inc. | $4.92 | −11.03% | −26.13% | −25.45% | Sep 14, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% | Aug 27, 2026 |
| HYFT | MindWalk Holdings Corp. | $1.43 | +5.15% | −29.21% | −46.04% | Sep 14, 2026 |
| LYTIX.OL | Lytix Biopharma ASA | 7.78 NOK | −11.59% | −22.04% | −4.19% | Aug 27, 2026 |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% | Sep 2, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% | Aug 28, 2026 |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% | Aug 27, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% | Sep 10, 2026 |
| SVA.TO | Sernova Biotherapeutics Inc | 0.11 CAD | −8.33% | −15.38% | −42.11% | Sep 10, 2026 |
| CONTX.OL | ContextVision AB (publ) | 3.55 NOK | +3.20% | −14.46% | −21.11% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% | Sep 15, 2026 |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% | Aug 31, 2026 |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% | Sep 23, 2026 |
| CLGN | CollPlant Biotechnologies Ltd. | $0.31 | −6.25% | −79.22% | −89.43% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.